Aurora Cannabis Inc. (TSE:ACB) Given Average Recommendation of "Moderate Buy" by Brokerages

Aurora Cannabis Inc. (TSE:ACB - Get Free Report) has received a consensus rating of "Moderate Buy" from the five research firms that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and two have assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is C$7.11.

ACB has been the subject of several research reports. TD Securities raised shares of Aurora Cannabis to a "strong-buy" rating in a report on Thursday, December 12th. Atb Cap Markets upgraded shares of Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 5th. Finally, ATB Capital cut their target price on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday, December 17th.

Aurora Cannabis Stock Down 1.4 %

Aurora Cannabis stock traded down C$0.13 during trading hours on Friday, hitting C$9.06. 528,322 shares of the stock traded hands, compared to its average volume of 663,991. The firm's 50-day moving average price is C$6.30 and its two-hundred day moving average price is C$7.20. The company has a current ratio of 3.76, a quick ratio of 2.48 and a debt-to-equity ratio of 16.95. The company has a market cap of C$495.22 million, a PE ratio of -14.38 and a beta of 2.71. Aurora Cannabis has a one year low of C$3.84 and a one year high of C$12.85.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.